MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $610,026 | -80.6% | 104,100 | -77.6% | 0.00% | -66.7% |
| Q3 2022 | $3,147,728 | +3051.0% | 465,600 | +2055.6% | 0.01% | – |
| Q2 2022 | $99,896 | +16.0% | 21,600 | 0.0% | 0.00% | – |
| Q1 2022 | $86,092 | -90.7% | 21,600 | -85.4% | 0.00% | -100.0% |
| Q4 2021 | $921,000 | -83.1% | 148,000 | -27.8% | 0.00% | -88.2% |
| Q4 2020 | $5,456,000 | +48.9% | 205,042 | +4.2% | 0.02% | +30.8% |
| Q3 2020 | $3,664,000 | -69.7% | 196,766 | -62.0% | 0.01% | -45.8% |
| Q2 2020 | $12,108,000 | +189.7% | 517,394 | -27.8% | 0.02% | +140.0% |
| Q1 2020 | $4,180,000 | – | 716,954 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |